Daily variation in non-protein sulfhydryl levels of human bone marrow

William T. Bellamy, David S Alberts, Robert T Dorr

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

There is increasing evidence that the dosing of certain antineoplastic agents based on a circadian type of schedule may have a beneficial effect on the outcome of patient therapy. Such regimens allow for a more intensive course of drugs to be administered due to a reduction in the toxicities associated with these agents. Since many of the antineoplastics in use today either form reactive intermediates or generate toxic free radical species within the cell, cellular thiols such as glutathione may play a role in their detoxification. Our studies were designed to investigate whether there exists a consistent daily fluctuation in the thiol content in human bone marrow samples. Five normal male volunteers, ages 26-32 years, underwent repeat bone marrow aspirations at approx. 8 a.m. and 8 p.m. Mean peak non-protein sulfhydryl (NPSH) levels of 47.7 nmol/mg protein occurred in morning bone marrow aspirates while evening aspirates showed markedly reduced mean levels of 7.9 nmole/mg protein. Reduced glutathione was used as a standard in these assays which measured sulfhydryls spectrophotometrically using Ellman's reagent. Our findings may help to explain the observed reduction in myelotoxicity in chemotherapy designed to take advantage of human circadian rhythms. These results support the proposition that the administration of certain cytotoxic drugs to match peak levels of thiois in the marrow may facilitate more intensive and active chemotherapy regimens.

Original languageEnglish (US)
Pages (from-to)1759-1762
Number of pages4
JournalEuropean Journal of Cancer and Clinical Oncology
Volume24
Issue number11
DOIs
StatePublished - 1988

Fingerprint

Bone Marrow
Sulfhydryl Compounds
Antineoplastic Agents
Glutathione
Dithionitrobenzoic Acid
Drug Therapy
Poisons
Circadian Rhythm
Pharmaceutical Preparations
Free Radicals
Appointments and Schedules
Healthy Volunteers
Proteins
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Daily variation in non-protein sulfhydryl levels of human bone marrow. / Bellamy, William T.; Alberts, David S; Dorr, Robert T.

In: European Journal of Cancer and Clinical Oncology, Vol. 24, No. 11, 1988, p. 1759-1762.

Research output: Contribution to journalArticle

@article{034d4f83b382448999c4d7ad031e930e,
title = "Daily variation in non-protein sulfhydryl levels of human bone marrow",
abstract = "There is increasing evidence that the dosing of certain antineoplastic agents based on a circadian type of schedule may have a beneficial effect on the outcome of patient therapy. Such regimens allow for a more intensive course of drugs to be administered due to a reduction in the toxicities associated with these agents. Since many of the antineoplastics in use today either form reactive intermediates or generate toxic free radical species within the cell, cellular thiols such as glutathione may play a role in their detoxification. Our studies were designed to investigate whether there exists a consistent daily fluctuation in the thiol content in human bone marrow samples. Five normal male volunteers, ages 26-32 years, underwent repeat bone marrow aspirations at approx. 8 a.m. and 8 p.m. Mean peak non-protein sulfhydryl (NPSH) levels of 47.7 nmol/mg protein occurred in morning bone marrow aspirates while evening aspirates showed markedly reduced mean levels of 7.9 nmole/mg protein. Reduced glutathione was used as a standard in these assays which measured sulfhydryls spectrophotometrically using Ellman's reagent. Our findings may help to explain the observed reduction in myelotoxicity in chemotherapy designed to take advantage of human circadian rhythms. These results support the proposition that the administration of certain cytotoxic drugs to match peak levels of thiois in the marrow may facilitate more intensive and active chemotherapy regimens.",
author = "Bellamy, {William T.} and Alberts, {David S} and Dorr, {Robert T}",
year = "1988",
doi = "10.1016/0277-5379(88)90078-8",
language = "English (US)",
volume = "24",
pages = "1759--1762",
journal = "European Journal of Cancer and Clinical Oncology",
issn = "0277-5379",
publisher = "Pergamon Press",
number = "11",

}

TY - JOUR

T1 - Daily variation in non-protein sulfhydryl levels of human bone marrow

AU - Bellamy, William T.

AU - Alberts, David S

AU - Dorr, Robert T

PY - 1988

Y1 - 1988

N2 - There is increasing evidence that the dosing of certain antineoplastic agents based on a circadian type of schedule may have a beneficial effect on the outcome of patient therapy. Such regimens allow for a more intensive course of drugs to be administered due to a reduction in the toxicities associated with these agents. Since many of the antineoplastics in use today either form reactive intermediates or generate toxic free radical species within the cell, cellular thiols such as glutathione may play a role in their detoxification. Our studies were designed to investigate whether there exists a consistent daily fluctuation in the thiol content in human bone marrow samples. Five normal male volunteers, ages 26-32 years, underwent repeat bone marrow aspirations at approx. 8 a.m. and 8 p.m. Mean peak non-protein sulfhydryl (NPSH) levels of 47.7 nmol/mg protein occurred in morning bone marrow aspirates while evening aspirates showed markedly reduced mean levels of 7.9 nmole/mg protein. Reduced glutathione was used as a standard in these assays which measured sulfhydryls spectrophotometrically using Ellman's reagent. Our findings may help to explain the observed reduction in myelotoxicity in chemotherapy designed to take advantage of human circadian rhythms. These results support the proposition that the administration of certain cytotoxic drugs to match peak levels of thiois in the marrow may facilitate more intensive and active chemotherapy regimens.

AB - There is increasing evidence that the dosing of certain antineoplastic agents based on a circadian type of schedule may have a beneficial effect on the outcome of patient therapy. Such regimens allow for a more intensive course of drugs to be administered due to a reduction in the toxicities associated with these agents. Since many of the antineoplastics in use today either form reactive intermediates or generate toxic free radical species within the cell, cellular thiols such as glutathione may play a role in their detoxification. Our studies were designed to investigate whether there exists a consistent daily fluctuation in the thiol content in human bone marrow samples. Five normal male volunteers, ages 26-32 years, underwent repeat bone marrow aspirations at approx. 8 a.m. and 8 p.m. Mean peak non-protein sulfhydryl (NPSH) levels of 47.7 nmol/mg protein occurred in morning bone marrow aspirates while evening aspirates showed markedly reduced mean levels of 7.9 nmole/mg protein. Reduced glutathione was used as a standard in these assays which measured sulfhydryls spectrophotometrically using Ellman's reagent. Our findings may help to explain the observed reduction in myelotoxicity in chemotherapy designed to take advantage of human circadian rhythms. These results support the proposition that the administration of certain cytotoxic drugs to match peak levels of thiois in the marrow may facilitate more intensive and active chemotherapy regimens.

UR - http://www.scopus.com/inward/record.url?scp=0023787258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023787258&partnerID=8YFLogxK

U2 - 10.1016/0277-5379(88)90078-8

DO - 10.1016/0277-5379(88)90078-8

M3 - Article

C2 - 3208818

AN - SCOPUS:0023787258

VL - 24

SP - 1759

EP - 1762

JO - European Journal of Cancer and Clinical Oncology

JF - European Journal of Cancer and Clinical Oncology

SN - 0277-5379

IS - 11

ER -